Abstract B019: Estimating the costs and cost-effectiveness of promoting mammography screening among US-based Latinas

Catherine M. Pichardo(National Institutes of Health), Gloria D. Coronado(University of Arizona), Yamilé Molina(University of Illinois Chicago), Scott D. Ramsey(Fred Hutch Cancer Center), Sonia Bishop(Fred Hutch Cancer Center), Shirley A.A. Beresford(Fred Hutch Cancer Center), Donald L. Patrick(Donaldson (United States))
Cancer Epidemiology Biomarkers & Prevention
June 1, 2020
10.1158/1538-7755.disp19-b019
Cited by 0

Related Papers

Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2—Assessing Respondent Understanding
|Value in Health|2011|1.1k
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1—Eliciting Concepts for a New PRO Instrument
|Value in Health|2011|1.1k
Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer
|New England Journal of Medicine|2006|985
GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles—continuous outcomes
|Journal of Clinical Epidemiology|2012|761
Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis
|Health Affairs|2013|696